ENvue Medical (FEED) Cash from Investing Activities (2014 - 2026)
ENvue Medical (FEED) posted quarterly Cash from Investing Activities of -$17000.0 for Q1 2026, down 111.89% year-over-year from $143000.0 in Q1 2025, and up 26.09% quarter-over-quarter from -$23000.0 in Q4 2025.
ENvue Medical (FEED) Cash from Investing Activities (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported Cash from Investing Activities for 11 consecutive years, with -$17000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 111.89% year-over-year to -$17000.0; the TTM figure through Mar 2026 stood at -$72000.0 (down 151.06% YoY), while the FY2025 annual figure was $88000.0, up 3033.33% from the prior year.
- Cash from Investing Activities rose to -$17000.0 in Q1 2026 per FEED's latest filing, from -$23000.0 in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $143000.0 in Q1 2025 and bottomed at -$28000.0 in Q3 2025.
- Historically, Cash from Investing Activities has averaged $6600.0 across 5 years, with a median of -$2000.0 in 2022.
- Annual changes were most pronounced in 2025 — Cash from Investing Activities surged 14400.0% — and 2026, when it sank 111.89%.
- ENvue Medical's Cash from Investing Activities stood at $1000.0 in 2022, then slumped by 200.0% to -$1000.0 in 2023, then sank by 100.0% to -$2000.0 in 2024, then plunged by 1050.0% to -$23000.0 in 2025, then rose by 26.09% to -$17000.0 in 2026.
- Business Quant data shows FEED's Cash from Investing Activities at -$17000.0 in Q1 2026, -$23000.0 in Q4 2025, and -$28000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.90 Bn | 193.29 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 129.12 Bn | 125.64 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 119.32 Bn | 110.10 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.63 Bn | 73.09 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 52.14 Bn | 47.89 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.54 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 34.06 Bn | 31.95 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | -108.50 Mn |
| 10 | ENvue Medical | 2.52 Mn | 1.38 Mn | -266,000.00 | -27,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -27,000.00 |
| Jun 30, 2026 | -27,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Mar 31, 2026 | -17,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Dec 31, 2025 | -23,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Sep 30, 2025 | -28,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Mar 31, 2025 | 143,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |